Trials / Unknown
UnknownNCT04380844
Effects of an Activity Control System in Patients With Diabetes: a Randomized Controlled Trial
Effects of an Activity Control System in Patients With Diabetes: a Randomized
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Maimónides Biomedical Research Institute of Córdoba · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Using a smart device (Beprevent) to monitor activities of daily living improves the lifestyle of patients with DM2
Detailed description
A 6-month randomized clinical trial to evaluate a home activity control system (Beprevent) in the management of the patient with DM2, through the individualized labeling of objects related to them. The study will include 20 patients with DM2 (10 in the intervention group and 10 in the control group) who live alone or with people who can´t move on their own. Data will be recorded to measure the degree of satisfaction of professionals and participants in the study, and clinical and epidemiological data at the start of the study (in its baseline situation) and at the end of the study (at 6 months), to assess the changes produced and Compare them between both study groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Beprevent | 10 will become part of the intervention group. At first, they are given a series of questionnaires, later (1 day later) we stay at their home to install the Beprevent device, which will remain in their home for a period of two weeks, to finish and once the device of your home, we will proceed to pass the same questionnaires as at the beginning of the test, in order to compare results. |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2021-05-01
- Completion
- 2021-11-01
- First posted
- 2020-05-08
- Last updated
- 2020-12-24
Source: ClinicalTrials.gov record NCT04380844. Inclusion in this directory is not an endorsement.